The Research and Development team at Vernalis is responsible for identifying and developing lead compounds and clinical candidates targeting oncology, neurodegeneration, inflammation, and anti-infectives. This multidisciplinary group combines expertise in biology, chemistry, medicinal and computational chemistry, protein crystallography, and NMR to advance drug discovery and development.